Form 8-K · Current report
ResMed| 8-K, filed Sep 1, 2026
- Filed
- CIK
- 0000943819
- Accession no.
- 0001193125-26-378487
Summary
ResMed Inc. entered into an accelerated share repurchase agreement with Citibank, N.A. on August 31, 2026 to repurchase $450.0 million of its common stock, using proceeds from the sale of its MatrixCare business and cash on hand. Final settlement is scheduled for December 2026, though Citibank may elect to complete it earlier.
Key points
- ResMed will pay Citibank $450.0 million on September 3, 2026 and expects an initial delivery of shares equal to 80% of that amount divided by the September 2, 2026 closing price.
- The repurchase is under a board authorization approved in February 2014 for up to 20,000,000 shares.
- The final number of shares repurchased will be based on the daily volume-weighted average price during the agreement term, less a discount and subject to adjustments.
- The transaction was contemplated in ResMed's fiscal year 2027 guidance issued during its Q4 FY26 earnings call on August 6, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
From the filing
Item 8.01. Other Events. On August 31, 2026, ResMed Inc. (the “Company”) entered into an accelerated share repurchase agreement (the “ASR Agreement”) with Citibank, N.A. (“Citibank”) to repurchase $450.0 million of the Company’s shares of common stock, par value $0.004 per share (“Common Stock”). The Company is conducting the accelerated share repurchase under a repurchase authorization for an aggregate of 20,000,000 shares of Common Stock approved by its board of directors in February 2014. The Company intends to fund the accelerated share repurchase with the proceeds from the sale of its MatrixCare business and cash on hand. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.